Ali Bashashati

Dr. Ali Bashashati


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 December 2012 in Genome Biology
Verified
Journal Article
Open access
PDF file
ABAli Bashashati
Ali Bashashati
GHGholamreza Haffari
Gholamreza Haffari
JDJiarui Ding
Jiarui Ding
GHGavin Ha
Gavin Ha
KLKenneth Lui
Kenneth Lui
SSSohrab P Shah
Sohrab P Shah
Simultaneous interrogation of tumor genomes and transcriptomes is underway in unprecedented global efforts. Yet, despite the essential need to separate driver mutations modulating gene expression networks from transcriptionally inert passenger mutations, robust computational methods to ascertain the impact of individual mutations on transcriptional networks are underdeveloped. We introduce a novel computational framework, DriverNet, to identify likely driver mutations by virtue of their effect on mRNA expression networks. Application to four cancer datasets reveals the prevalence of rare candidate driver mutations associated with disrupted transcriptional networks and a simultaneous modulation of oncogenic and metabolic networks, induced by copy number co-modification of adjacent oncogenic and metabolic drivers. DriverNet is available on Bioconductor or at http://compbio.bccrc.ca/software/drivernet/.

19 July 2020 in The Journal of Pathology
Verified
Journal Article
Closed access
PDF file
ALAdrian B. Levine
Adrian B. Levine
JPJason Peng
Jason Peng
DFDavid Farnell
David Farnell
MNMitchell Nursey
Mitchell Nursey
YWYiping Wang
Yiping Wang
ABAli Bashashati
Ali Bashashati

5 September 2022 in Laboratory Investigation
Verified
Journal Article
Closed access
PDF file
HFHossein Farahani
Hossein Farahani
JBJeffrey Boschman
Jeffrey Boschman
DFDavid Farnell
David Farnell
ADAmirali Darbandsari
Amirali Darbandsari
AZAllen Zhang
Allen Zhang
ABAli Bashashati
Ali Bashashati

6 December 2009 in Advances in Bioinformatics
Verified
Journal Article
Open access
PDF file
ABAli Bashashati
Ali Bashashati
RBRyan R. Brinkman
Ryan R. Brinkman
Flow cytometry (FCM) is widely used in health research and in treatment for a variety of tasks, such as in the diagnosis and monitoring of leukemia and lymphoma patients, providing the counts of helper-T lymphocytes needed to monitor the course and treatment of HIV infection, the evaluation of peripheral blood hematopoietic stem cell grafts, and many other diseases. In practice, FCM data analysis is performed manually, a process that requires an inordinate amount of time and is error-prone, nonreproducible, nonstandardized, and not open for re-evaluation, making it the most limiting aspect of this technology. This paper reviews state-of-the-art FCM data analysis approaches using a framework introduced to report each of the components in a data analysis pipeline. Current challenges and possible future directions in developing fully automated FCM data analysis tools are also outlined.

20 September 2021 in The Journal of Pathology
Verified
Journal Article
Closed access
PDF file
JBJeffrey Boschman
Jeffrey Boschman
HFHossein Farahani
Hossein Farahani
ADAmirali Darbandsari
Amirali Darbandsari
PAPouya Ahmadvand
Pouya Ahmadvand
ASAshley Van Spankeren
Ashley Van Spankeren
ABAli Bashashati
Ali Bashashati

19 July 2024 in npj Precision Oncology
Verified
Journal Article
Open access
PDF file
MAMaryam Asadi-Aghbolaghi
Maryam Asadi-Aghbolaghi
ADAmirali Darbandsari
Amirali Darbandsari
AZAllen Zhang
Allen Zhang
ACAlberto Contreras-Sanz
Alberto Contreras-Sanz
JBJeffrey Boschman
Jeffrey Boschman
ABAli Bashashati
Ali Bashashati
Investigation of histopathology slides by pathologists is an indispensable component of the routine diagnosis of cancer. Artificial intelligence (AI) has the potential to enhance diagnostic accuracy, improve efficiency, and patient outcomes in clinical pathology. However, variations in tissue preparation, staining protocols, and histopathology slide digitization could result in over-fitting of deep learning models when trained on the data from only one center, thereby underscoring the necessity to generalize deep learning networks for multi-center use. Several techniques, including the use of grayscale images, color normalization techniques, and Adversarial Domain Adaptation (ADA) have been suggested to generalize deep learning algorithms, but there are limitations to their effectiveness and discriminability. Convolutional Neural Networks (CNNs) exhibit higher sensitivity to variations in the amplitude spectrum, whereas humans predominantly rely on phase-related components for object recognition. As such, we propose Adversarial fourIer-based Domain Adaptation (AIDA) which applies the advantages of a Fourier transform in adversarial domain adaptation. We conducted a comprehensive examination of subtype classification tasks in four cancers, incorporating cases from multiple medical centers. Specifically, the datasets included multi-center data for 1113 ovarian cancer cases, 247 pleural cancer cases, 422 bladder cancer cases, and 482 breast cancer cases. Our proposed approach significantly improved performance, achieving superior classification results in the target domain, surpassing the baseline, color augmentation and normalization techniques, and ADA. Furthermore, extensive pathologist reviews suggested that our proposed approach, AIDA, successfully identifies known histotype-specific features. This superior performance highlights AIDA’s potential in addressing generalization challenges in deep learning models for multi-center histopathology datasets.